Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 64 clinical trials
Featured trial
Safety & Efficacy Study of Relamorelin in Diabetic Gastroparesis

This trial studies the safety and effectiveness of an experimental drug for diabetic gastroparesis.

  • 78 views
  • 13 Aug, 2019
  • 1 location
Featured trial
The purpose of this study is to compare the safety and effects, good or bad, of MSTT1041A versus placebo on patients with moderate to severe atopic dermatitis.

The purpose of this study is to compare the safety and effects, good or bad, of MSTT1041A versus placebo on patients with moderate to severe atopic dermatitis. 

  • 143 views
  • 23 Nov, 2020
  • 1 location
Featured trial
A Phase 2 Study of Sitravatinib in Combination with Nivolumab in Patients with Advanced or Metastatic Urothelial Carcinoma (516-003)

This is a study involving an investigational (experimental) drug called sitravatinib, given in combination with the immunotherapy nivolumab (also known as OPDIVO®).  Sitravatinib

advanced urothelial carcinoma
advanced urothelial cancer
carcinoma
platinum-based chemotherapy
nivolumab
  • 86 views
  • 02 Jun, 2021
  • 1 location
CAR-T Followed by Bispecific Antibodies

The research study is being conducted to test the safety and effectiveness of the experimental drug mosunetuzumab (Cohort 1) or obinutuzumab and glofitamab (Cohort 2) when given after CAR

  • 0 views
  • 23 Mar, 2022
  • 1 location
Neoadjuvant-Adjuvant Pembrolizumab in Resectable Advanced Basal Cell Carcinoma of H&N

> Pembrolizumab, is an investigational (experimental) drug that may improve the response of the immune system against cancer. Pembrolizumab is a manufactured antibody, much like the antibodies usually made by the

  • 0 views
  • 23 Apr, 2022
  • 1 location
Trial to Compare the Efficacy and Safety Of MW05 and PEG-rhG-CSF

day of each cycle randomized 1:1:1 . The dose of the experimental drug MW05 in phase III were determined by independent data monitoring committee (IDMC) according to the efficacy and safety of

  • 0 views
  • 26 Jan, 2021
  • 1 location
A Study of Anti-IL-6R mAb Injection in Patients With iMCD

This study is a single-arm, open-label, multicenter, dose-escalation clinical study.Its primary purpose is to evaluate the safety and tolerability of recombinant humanized anti-interleukin-6 receptor monoclonal antibody ( Anti-IL-6R mAb ) injection in patients with Idiopathic Multicentric Castleman's Disease ( iMCD ) and to determine the recommended dose for follow-up studies. …

  • 0 views
  • 10 May, 2022
  • 1 location
Study to Assess Safety, Reactogenicity and Immunogenicity of the VACCINE RNA MCTI CIMATEC HDT (HDT-301) Vaccine Against COVID-19

This is a phase I, double-blind, placebo-controlled,dose-ranging clinical trial in healthy males and non-pregnant females, 18 to 55 years of age. The trial is designed to assess the safety, reactogenicity, and immunogenicity of VACCINE RNA MCTI CIMATEC HDT(HDT-301), which is a novel Lipid-Inorganic Nanoparticle (LION) formulated replicating RNA-based vaccine that …

Accepts healthy volunteers
  • 0 views
  • 23 Apr, 2022
  • 1 location
Safety and Effectiveness of Quizartinib in Children and Young Adults With Acute Myeloid Leukemia (AML), a Cancer of the Blood

Quizartinib is an experimental drug. It is not approved for regular use. It can only be used in medical research. Children or young adults with a certain kind of blood cancer (FLT3-ITD

methotrexate
remission
consolidation therapy
hematologic malignancy
flt3 internal tandem duplication
  • 39 views
  • 18 May, 2022
  • 38 locations
IMCY-0098 Proof of ACtion in Type 1 Diabetes (IMPACT Study)

The IMPACT study is a study to test a new experimental drug, IMCY-0098, for the treatment of type 1 diabetes (T1D). In most people with type 1 diabetes, the pancreas loses its ability to

  • 4 views
  • 15 Nov, 2021
  • 22 locations